Mongolia vs New Zealand: Proportion of isolates with decreased susceptibility or resistance
Mongolia
0.7752
in 2018
New Zealand
0.1
in 2020
Mongolia rank
9th
New Zealand rank
11th
Proportion of isolates with decreased susceptibility or resistance over time
- Mongolia
- New Zealand
How they compare
Mongolia currently reports 0.7752 against 0.1 in New Zealand, a difference of 0.6752.
That makes Mongolia's figure about 7.8 times New Zealand's.
The two have swapped places 2 times across 5 shared years of data; in 2009 it was Mongolia ahead.
Mongolia ranks 9th and New Zealand ranks 11th of 52 countries.
Mongolia has averaged higher in every one of the 2 decades both report.
Head to head by decade
| Decade | Mongolia | New Zealand | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 19.13 | 0 | 19.13 | Mongolia |
| 2010s | 13.97 | 0.4393 | 13.53 | Mongolia |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher proportion of isolates with decreased susceptibility or resistance, Mongolia or New Zealand?
- Mongolia, at 0.7752 against 0.1 in New Zealand as of 2018.
- What is the difference in proportion of isolates with decreased susceptibility or resistance between Mongolia and New Zealand?
- 0.6752, with Mongolia ahead.
- How many years of comparable data are there for Mongolia and New Zealand?
- 5 years are reported by both, from 2009 to 2017.
- How do Mongolia and New Zealand rank globally for proportion of isolates with decreased susceptibility or resistance?
- Mongolia ranks 9th and New Zealand ranks 11th of 52 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as Proportion of isolates with decreased susceptibility or resistance (DS/R) to ceftriaxone reported to WHO-GASP. Statizoid refreshes it automatically from the source and publishes the full history for both places.